期刊文献+

PLLA-PTX微粒的缓释及对人卵巢癌SKOV3细胞的抑瘤作用 被引量:1

Controlled Release of Paclitaxel from Microparticles Containing PLLA and Its Anti-tumor Activity on Human Ovarian Carcinoma Cell Line SKOV3
下载PDF
导出
摘要 目的证明聚左旋乳酸-紫杉醇(PLLA-PTX)微粒影响SKOV3细胞增殖和凋亡的有效性;探讨生物降级高分子材料聚左旋乳酸(PLLA)对所担载抗肿瘤药物紫杉醇(PTX)的缓释作用。方法实验分为PLLA-PTX微粒组、PTX组和空白对照组。MTT比色法检测细胞的增殖情况;倒置显微镜观察细胞形态学变化;FCM技术进行细胞凋亡及周期分析;TUNEL检测、定位凋亡细胞。结果PLLA-PTX微粒能有效的抑制SKOV3细胞的增殖,具剂量和时间依赖性。其抑瘤作用明显优于裸露的PTX,随时间的延长,优势不断增大。PLLA-PTX微粒的最佳实验浓度为0.05μmol/L。倒置显微镜下,PLLA-PTX微粒组和PTX组培养液中漂浮大量体积变圆的细胞和颗粒状无定形碎片,随时间的延长,PLLA-PTX微粒组更明显。PLLA-PTX微粒组和PTX组肿瘤细胞凋亡率均高于对照组(P<0.05)。随时间的延长,PLLA-PTX微粒提高细胞凋亡率、增加G2/M期细胞比例的优势大于PTX组。TUNEL可以准确定位PLLA-PTX微粒作用后正在凋亡的细胞,同时出现了两种独特细胞:病理性核分裂象细胞和多微核细胞。结论PLLA-PTX微粒具有较强的细胞毒作用及明显的缓释作用,可以维持较长时间的有效浓度,持续抑制SKOV3细胞的增殖。 Objective To prove the PLLA-PTX' efficacy on growth, apoptosis of ovarian cancer cell line SKOV3, and to study the controlled release roles of PLLA for PTX. Methods Cultured cells of human ovarian Carcinoma cell Line SKOV3 were treated with PLLA-PTX microparticles and PTX only separately, untreated cells as the control. The proliferation of SKOV3 cells were determined by MTT assay with the morphologic change observed under inverted phase contrast microscope, the apoptosis of cell were demonstrated by FCM and in situ TUNEL technique. Results The anti-tumor activity of PLLA-PTX microparticles was stronger than PTX alone. A time-dependent and dose-dependent growth inhibition was abserved. At 0.05 μmol/L drug concentration, SKOV3 cell viability experiment demonstrated that the drug formulated in the microparticles was more effective than that formulated in PTX. PLLA-PTX microparticles can increase G2/M period percentage, interrupt the cell cycle proceeding, and inhibit the tumor cells'growth through cell apoptosis. Positive staining for the presence of apoptosis were obtained in SKOV3 cells with PLLA-PTX microparticles. Conclusions PLLA-PTX microparticles have strong anti-tumor activity and obviously controlled released effectiveness. It shows longer and stronger controlled antitumor activity than paclitaxel alone.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2009年第2期212-216,共5页 Journal of Sichuan University(Medical Sciences)
基金 四川省科技厅科技攻关项目(2006Z09-033) 四川省科技厅重点科技攻关项目(2006Z08-001-1)资助
关键词 聚左旋乳酸 紫杉醇 缓释 卵巢癌 抑瘤 PLLA Paclitaxel Controlled release Ovarian carcinoma Anti-tumor activity
  • 相关文献

参考文献12

  • 1Rowinsky EK, Cazenave LA, Donehower RC. Taxoh a novel investigatlonal antimicrotubule agent. J Natl Cancer Inst, 1990,82(15):1247-1259.
  • 2Bernstein BJ. Docetaxel as an alternative to paclitaxel after acute hypersensitivity reactions. Ann Pharmacother, 2000, 34 (11):1332-1335.
  • 3Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm,2002,235(1-2) :179-192.
  • 4Liggins RT, Burt HM. Paclitaxel loaded poly (1-lactic acid) (PLLA) microspheres II: the effect of processing parameters on microspere morphology and drug release kinetics. Int J Pharm, 2004 ; 281 (2) : 103-106.
  • 5赵锋,高永良.聚乳酸微球生物降解机制和生物相容性研究进展[J].中国新药杂志,2002,11(1):67-71. 被引量:19
  • 6Nico la E, Macro B, Paolo P, et al. Production of different morphologies of biocompatible polymeric materials by supercritieal CO2 antisolvent techniques. Biotechnology and Bioengineering,2001 ;73(6) :449-457.
  • 7Kang Y, Wu J, Yin G, et al. Characterization and biological evaluation of paclitaxel-loaded poly ( L-lactic acid ) microparticles prepared by supercritieal CO2. Langmuir,2008 24(14) :7432-7441.
  • 8Kang BK, Chon SK, Kim SH, et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm,2004, 286(1-2): 147-156.
  • 9Ahn HJ, Kim YS, Kim JU, etal. Mechanism of taxol-induced apoptosis in human SKVO3 ovarian carcinoma cells. Journal of Cellular Biochemlstry,2004,91 (5):1043-1052.
  • 10卞丽红,王洪权,窦园园,章扬培.紫杉醇/海藻酸钠微囊/微球的缓释及抑瘤作用研究[J].军事医学科学院院刊,2005,29(2):152-155. 被引量:6

二级参考文献32

  • 1陈庆华,瞿文.多肽、蛋白质药物的微球给药系统研究进展[J].国外医学(药学分册),1997,24(3):129-133. 被引量:20
  • 2[1]Anderson JM.Perspectives on the in vivo responses of biodegradable polymers[A].In:Biomedical applications of synthetic biodegradable polymers[M].Boca Raton:CRC Press,FL,1995.223-233.
  • 3[2]Okada H,Toguchi H.Biodegradable microspheres in drug delivery[J].Crit Rev Therap,1995,12∶1-99.
  • 4[3]Li S,Vert M.Biodegradation of aliphatic polyesters[A],In:Scott G,Gilead D eds.Degradable Polymers[M].London:Chapman and Hall.1995.43-87.
  • 5[4]Schakenraad JM,Hardon MJ,Feijen J,et al.Enzymatic activity toward poly(L-Lactic acid)implants[J].J Biomed Mater Res,1990,24∶529-545.
  • 6[5]Bodmeier R,Chen H.Effect of the addition of low molecular weight poly(dl-lactide)on drug release from biodegradable poly(dl-lactide) drug delivery system[J].Int J Pharm,1989,51∶1-8.
  • 7[6]Vert M,Mauduit J,Li S.Biodegradation of PLA/GA polymers: increasing complexity[J].Biomaterials,1994,15∶1209-1213.
  • 8[7]Grizzi I,Garreau H,Li S,et al.Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence[J].Biomaterials,1995,16∶305-311.
  • 9[8]Spenlehauer G,Vert M,Benoit JP,et al.In vitro and in vivo degradation of poly(DL-lactide/glycolide) type microspheres made by solvent evaporation method[J].Biomaterials,1989,10∶557-563.
  • 10[9]Beck LR,Cowsar DR,Lewis DH.Systemic and local delivery of contraceptive steroids using biodegradable microspheres[A].In:Hafez ESE, WAA Van Os eds.Biodegradables and delivery systems for contraception[M].MTP Press Limited,1980. 63-82.

共引文献23

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部